LENZ THERAPEUTICS, INC. — Income Charts
6 quarters of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$13M
R&D↓-41.2% -$3M
$4M
SG&A↑+324.9% +$21M
$28M
D&A↑+1150.0% +$115K
$125K
Operating Income↓-45.9% -$6M
$-19M
EBITDA↓-45.0% -$6M
$-19M
Interest Income↓-19.6% -$535K
$2M
Other Income/Expense↓-133.3% -$8K
$-14K
Pretax Income↓-63.5% -$6M
$-17M
Tax Provision
$0
Net Income↓-63.5% -$6M
$-17M
Operating Margin
-151.1%
Net Margin
-133.6%
Effective Tax Rate↑+0.0pts
0.0%
ETR (Continuing Operations)
—
ETR Federal Statutory
—
ETR State + Local (pp)
—
Operating Lease Cost↑+0.0% +$0
$100K
Income YoY Variation↓-80.7pts
-45.9%
Revenue QoQ Variation
150.0%
Income QoQ Variation↓-21.8pts
-12.0%